[TXMD] TherapeuticsMD, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 6 Change: 0.28 (4.9%)
Ext. hours: Change: 0 (0%)

chart TXMD

Refresh chart

Description: TherapeuticsMD, Inc. operates as a women?s health care product company. The company manufactures and distributes branded and generic prescription prenatal vitamins, as well as over-the-counter vitamins and cosmetics. It offers prenatal vitamins, iron supplements, vitamin D supplements, natural menopause relief products, and cosmetic stretch mark creams under the vitaMedMD brand, as well as duplicate formulations of its prescription prenatal vitamins products under the BocaGreenMD Prena1 name. The company also focuses on conducting the clinical trials for hormone therapy pharmaceutical products that are designed to alleviate the symptoms of and reduce the health risks resulting from menopause-related hormone deficiencies, including hot flashes, osteoporosis, and vaginal dryness. TherapeuticsMD markets its products primarily through a direct national sales force to health care providers, as well as directly through its Website. The company was founded in 2008 and is headquartered in Boca Raton, Florida.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 19.27% Sales Growth - Q/Q5.1% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-66.27% ROE-75.16% ROI
Current Ratio8.7 Quick Ratio8.61 Long Term Debt/Equity Debt Ratio0.13
Gross Margin76.69% Operating Margin-395.98% Net Profit Margin-395.47% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities59.48 M Cash From Investing Activities-40 K Cash From Operating Activities-19.15 M Gross Profit3.43 M
Net Profit-20.89 M Operating Profit-20.92 M Total Assets99.48 M Total Current Assets96.71 M
Total Current Liabilities11.11 M Total Debt Total Liabilities11.77 M Total Revenue4.48 M
Technical Data
High 52 week7.42 Low 52 week3.56 Last close4.23 Last change0.71%
RSI16.67 Average true range0.18 Beta0.08 Volume1.72 M
Simple moving average 20 days-10.95% Simple moving average 50 days-19.55% Simple moving average 200 days-21.3%
Performance Data
Performance Week-8.64% Performance Month-23.37% Performance Quart-19.27% Performance Half-29.15%
Performance Year-27.32% Performance Year-to-date11.02% Volatility daily1.58% Volatility weekly3.54%
Volatility monthly7.26% Volatility yearly25.16% Relative Volume90.61% Average Volume2.78 M
New High New Low

News

2019-06-12 07:25:35 | Jim Cramer Shares His Thoughts On TherapeuticsMD, Rite Aid And More

2019-06-11 08:02:33 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-06-10 09:39:01 | TherapeuticsMD Enters Agreement to Market Drugs Outside US

2019-06-10 08:03:34 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-06-10 07:00:00 | TherapeuticsMD to Host Investor and Analyst Day Today

2019-06-07 07:15:00 | TherapeuticsMD and Theramex Enter into Exclusive License and Supply Agreement to Commercialize BIJUVA™ and IMVEXXY® Outside the United States

2019-06-06 08:06:53 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-06-04 08:02:42 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-05-29 07:00:00 | TherapeuticsMD to Host Investor and Analyst Day on June 10, 2019 in New York City

2019-05-08 07:00:00 | TherapeuticsMD Announces Participation at the Bank of America Merrill Lynch 2019 Health Care Conference

2019-05-07 14:06:00 | Here's Why TherapeuticsMD Fell as Much as 17.6% Today

2019-05-07 08:07:02 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-05-07 01:16:37 | Edited Transcript of TXMD earnings conference call or presentation 6-May-19 8:30pm GMT

2019-05-06 22:14:07 | TherapeuticsMD Inc TXMD Q1 2019 Earnings Call Transcript

2019-05-06 18:45:10 | TherapeuticsMD TXMD Reports Q1 Loss, Misses Revenue Estimates

2019-05-06 17:33:37 | TherapeuticsMD: 1Q Earnings Snapshot

2019-05-06 16:05:00 | TherapeuticsMD Announces First Quarter 2019 Financial Results

2019-05-06 08:50:12 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options

2019-05-06 07:00:00 | TherapeuticsMD Presented New Research at the American College of Obstetricians and Gynecologists 2019 Annual Meeting that Explores How Women’s Menopausal Symptoms Affect Men

2019-05-03 10:38:40 | Is TherapeuticsMD Inc TXMD A Good Stock To Buy?

2019-05-03 07:00:00 | TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the American College of Obstetricians and Gynecologists 2019 Annual Meeting

2019-05-02 07:20:00 | SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating TherapeuticsMD, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

2019-04-30 08:04:54 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-04-29 07:00:00 | TherapeuticsMD to Report First Quarter 2019 Results on May 6, 2019

2019-04-25 10:33:02 | Analysts Estimate TherapeuticsMD TXMD to Report a Decline in Earnings: What to Look Out for

2019-04-24 16:10:00 | TherapeuticsMD Closes $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners

2019-04-17 07:05:00 | TherapeuticsMD Signs Binding Commitment Letter for $300 Million Non-Dilutive Term Loan Financing Facility with TPG Sixth Street Partners

2019-04-17 07:00:00 | TherapeuticsMD Announces Commercial Availability of BIJUVA™ in the U.S.

2019-04-12 12:08:44 | Is TherapeuticsMD, Inc. NASDAQ:TXMD Overpaying Its CEO?

2019-04-06 08:03:00 | Here's Why Investors Are Betting Against These 2 Biotech Stocks

2019-03-28 08:05:00 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-03-25 07:00:00 | TherapeuticsMD Announces Oral and Poster Presentations on BIJUVA™ and ANNOVERA™ at the Endocrine Society 2019 Annual Meeting

2019-03-12 10:27:05 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-03-08 07:00:00 | TherapeuticsMD Announces Oral Presentations on BIJUVA and ANNOVERA, and Poster Presentations Related to Menopause Symptoms and Treatments at 2019 ISSWSH/ISSM Joint Meeting

2019-03-05 08:35:00 | Consolidated Research: 2019 Summary Expectations for TherapeuticsMD, Ensco plc, Cray, BeiGene, The Gap, and Nordson — Fundamental Analysis, Key Performance Indications

2019-03-05 08:03:31 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-02-28 07:00:00 | TherapeuticsMD Announces Participation in Two Upcoming Investor Conferences

2019-02-25 09:03:02 | TherapeuticsMD TXMD Catches Eye: Stock Jumps 6.1%

2019-02-22 09:11:53 | TherapeuticsMD, Inc. TXMD Q4 2018 Earnings Conference Call Transcript

2019-02-22 08:50:41 | The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data

2019-02-22 01:46:10 | Edited Transcript of TXMD earnings conference call or presentation 21-Feb-19 9:30pm GMT

2019-02-21 17:59:19 | TherapeuticsMD: 4Q Earnings Snapshot

2019-02-21 16:05:00 | TherapeuticsMD Announces Fourth Quarter and Full-Year 2018 Financial Results

2019-02-21 13:55:44 | Is TherapeuticsMD, Inc.’s NASDAQ:TXMD Balance Sheet Strong Enough To Weather A Storm?

2019-02-08 08:04:46 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-02-08 07:00:00 | TherapeuticsMD to Report Fourth Quarter and Full Year 2018 Results on February 21, 2019

2019-02-04 21:46:00 | Here's What Pushed TherapeuticsMD 37.8% Higher in January

2019-01-17 08:51:01 | Implied Volatility Surging for TherapeuticsMD TXMD Stock Options

2019-01-17 08:06:19 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.

2019-01-15 08:03:20 | See what the IHS Markit Score report has to say about TherapeuticsMD Inc.